Bextra may pose health risksJim S. Adler & Associates’ defective drug lawyers in Houston and throughout the state handle cases involving COX 2 inhibitors such as Bextra.Â
Bextra research conducted under the leadership of Dr. Garret FitzGerald, a cardiologist and pharmacologist at the University of Pennsylvania, indicates that individuals taking Bextra have a 219% greater chance of complications and risks involving: heart attack, stroke, sudden death, and/or Stevens Johnson Syndrome. Dr. FitzGerald, one of the world's leading COX-2 inhibitor experts, presented his research results to a meeting of the American Cardiology Association. Dr. Garret Fitzgerald, called Bextra, "A time bomb waiting to go off," and noted that the apparent dangers of Bextra exceed those associated with Vioxx.This is alarming news considering COX-2 drugs is a class of medicine that includes Vioxx, Bextra, and Celebrex, which is also made by Pfizer. Vioxx had sales of $2.5 billion last year, while Celebrex had sales of $1.8 billion and Bextra $687 million. Analysts project worldwide sales of Celebrex this year to be $3.4 billion and $1.3 billion for Bextra.
DISCLAIMER: Licensed to practice law in the state of Texas, Jim S. Adler & Associates, with principal offices at 3D/International Tower, 1900 West Loop South, 20th Floor, Houston, Texas 77027, also works as necessary with outside counsel and local counsel to litigate claims in the states of: Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | Florida | Georgia | Hawaii | Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico | New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee |Â Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin | Wyoming Additionally, Jim S. Adler & Associates has offices at City Place Building, 2711 North Haskell Ave., Suite 2100 LB40, Dallas, Texas 75204-2887; San Pedro Plaza, 7330 San Pedro Ave., Suite 700, San Antonio, Texas 78216-6237; and Bank of America, 12605 East Freeway, Suite 400, Houston, Texas 77015-5619 (serving Channelview, Texas). Bextra Lawyer | FDA requests Pfizer withdraw Bextra | WhatÂ’'s Wrong with Bextra? | How does Bextra cause Stevens-Johnson Syndrome? |







Bextra research conducted under the leadership of Dr. Garret FitzGerald, a cardiologist and pharmacologist at the University of Pennsylvania, indicates that individuals taking Bextra have a 219% greater chance of complications and risks involving: heart attack, stroke, sudden death, and/or Stevens Johnson Syndrome. Dr. FitzGerald, one of the world's leading COX-2 inhibitor experts, presented his research results to a meeting of the American Cardiology Association. Dr. Garret Fitzgerald, called Bextra, "A time bomb waiting to go off," and noted that the apparent dangers of Bextra exceed those associated with Vioxx.


